Key result
Statin myopathy may be a metabolic muscle disease caused by the metabolic effects of lipid-lowering in patients with underlying minor muscle disorders.
Population
Patients with statin myopathy
Design
Review
Authors
Loading...
May warrant caution prescribing statins to patients with muscle symptoms; leaves open metabolic screening before initiation.
This review proposes that statin myopathy is a metabolic muscle disease driven by the physiological effects of lipid-lowering rather than direct statin toxicity.
Phillips et al. (2008) conducted a review in Statin myopathy. Statins was evaluated. Statin myopathy may be a metabolic muscle disease caused by the metabolic effects of lipid-lowering in patients with underlying minor muscle disorders.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: